LHCG LHC Group Inc.

LHC Group and LifePoint Health to Form Joint Venture

LHC Group, Inc. (NASDAQ: LHCG) and LifePoint Health® (NASDAQ: LPNT) today announced plans to form a joint venture to strengthen home health and hospice services across the country. The organizations have signed a definitive agreement to share ownership and governance of a new joint venture that will operate LifePoint’s home health agencies and hospices, as well as select LHC Group agencies located near LifePoint hospitals. Combining the collective expertise of both organizations through this joint venture will enable the development and expansion of services for both companies.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161102005524/en/

“LHC Group and LifePoint Health share a deep commitment to compassionate, patient-centered care,” said Keith G. Myers, chairman and chief executive officer of LHC Group. “This partnership brings together two culturally aligned companies that are driven by a vision of expanding home health and hospice care, ensuring that patients and families in need of these services have access to them, and improving the health of communities.”

Under the terms of the definitive agreement, the joint venture will shift day-to-day operations management of LifePoint’s home health agencies and hospices, as well as all future home health and hospice acquisitions, to LHC Group. LifePoint’s home health agencies and hospices will continue to operate under their existing names. A newly-created joint venture governing board with equal representation of both companies will direct key governance decisions.

“We are eager to finalize our partnership with LHC Group and work together to enhance our existing home health and hospice services. This partnership further demonstrates our commitment to making communities healthier beyond the walls of our hospitals and across the continuum of care,” said William F. Carpenter III, chairman and chief executive officer of LifePoint Health. “Post-acute services are an increasingly important part of our business and our communities’ healthcare needs. By leveraging LHC Group’s expertise, we will gain access to the resources and the infrastructure needed to enhance our existing home health and hospice services, invest more in care coordination across our network, and expand access to these services in all our communities.”

LHC Group maintains 133 hospital and health system partnered home health and hospice locations, and more than 300 post-acute care locations across 25 states. LifePoint currently operates 20 home health and 10 hospice locations within its network of more than 70 hospitals in 22 states.

The joint venture is anticipated to commence operations at the end of 2016, subject to certain regulatory approvals and customary closing conditions.

About LHC Group, Inc.

LHC Group, Inc. is a national provider of non-acute healthcare services, providing quality, cost-effective healthcare to patients primarily within the comfort and privacy of their home or place of residence. LHC Group provides a comprehensive array of healthcare services through home health, hospice, community-based services agencies and long-term acute care hospitals (LTACHs). LHC Group operates more than 289 home health services locations, 64 hospice locations, 11 community-based service locations and six LTACHs with eight locations.

About LifePoint Health

LifePoint Health (NASDAQ: LPNT) is a leading healthcare company dedicated to Making Communities Healthier®. Through its subsidiaries, it provides quality inpatient, outpatient and post-acute services close to home. LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in 22 states. It is the sole community healthcare provider in the majority of the non-urban communities it serves. More information about the company can be found at www.LifePointHealth.net. All references to "LifePoint," "LifePoint Health" or the "Company" used in this release refer to affiliates or subsidiaries of LifePoint Health, Inc.

EN
02/11/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LHC Group Inc.

LHC GROUP reduces its risk exposure and slightly improves to Neutral

The independent financial analyst theScreener just allocated a lower risk rating to LHC GROUP (US), active in the Health Care Providers industry. As regards its fundamental valuation, the title still shows 3 out of 4 possible stars. Its market behaviour, however, has slightly improved and can be qualified as moderately risky. theScreener considers that these elements merit an overall rating upgrade to Neutral. As of the analysis date April 1, 2022, the closing price was USD 168.13 and its expect...

Valens Research
  • Valens Research

Valens Equity Insights and Inflections - D2021 10 12

LPL Financial (LPLA) has created a powerful platform to empower independent and smaller scale wealth advisors to compete with the big players like Merrill Lynch and Morgan Stanley. Uniform Accounting highlights the company's operational improvements that the market is missing, indicating equity upside. AMD Q2 2021 Embedded Expectations Analysis – Market expectations are for Uniform ROA to expand, but management may have concerns about data center revenue growth, EPYC processors, and operating c...

Valens Research
  • Valens Research

LHCG - Embedded Expectations Analysis - 2021 10 11

LHC Group, Inc. (LHCG:USA) currently trades around corporate averages relative to UAFRS-based (Uniform) earnings, with a 24.4x Uniform P/E, implying bullish expectations for the firm. However, management may have concerns about staffing challenges, cost management, and admissions growth. Specifically, management may lack confidence in their ability to gain stronger physician support for taking higher acuity patients into the home, forecast patient volumes and characteristics, and sustain organi...

LHC Group Inc: 1 director

A director at LHC Group Inc sold 5,000 shares at 201.620USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

 PRESS RELEASE

LHC Group to present at the Baird 2020 Global Healthcare Conference

LHC Group to present at the Baird 2020 Global Healthcare Conference LAFAYETTE, La., Sept. 08, 2020 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020. The presentation will begin at 8:30 a.m. Eastern time, and a live will be available. To access the live webcast, listeners should go to the section of the Company’s website, , approximately 15 minutes prior to the event to register and download any necessary software. About LHC Group, Inc.LHC Group, Inc. is a nat...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch